Asthma-associated risk for COVID-19 development.

"Disclosure of potential conflict of interest: C. Skevaki received consultancy fees and research funding from Hycor Biomedical and Thermo Fisher Scientific, research funding from Mead Johnson Nutrition, and consultancy fees from Bencard Allergie. The rest of the authors declare that they have no relevant conflicts of interest."

"H.R. is funded by the Universities Giessen Marburg Lung Center (UGMLC) and the German Center for Lung Disease (DZL German Lung Center, no. 82DZL00502) for UGMLC. C.S. is funded by UGMLC and the 10.13039/501100010564German Center for Lung Research, University Hospital Gießen and Marburg research funding according to article 2, section 3 cooperation agreement, the 10.13039/501100001659Deutsche Forschungsgemeinschaft (DFG)-funded Sonderforschungsbereich (SFB), Collaborative Research Center (CRC) (grant no. 1021 [C04]), the DFG-funded 10.13039/100003067KFO (Klinische Forschungsgruppe), Germany (grant no. 309 [P10]), and SK 317/1-1 (project number 428518790) as well as by the Foundation for Pathobiochemistry and Molecular Diagnostics."